José Luís
Zamorano Gómez
Catedrático/a de Universidad
![Foto de José Luís](/img/nophoto.png)
![Foto de University of Milan](/img/noimage_org.png)
University of Milan
Milán, ItaliaPublicacións en colaboración con investigadores/as de University of Milan (16)
2023
-
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 1-7
2021
2020
-
2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
European Heart Journal, Vol. 41, Núm. 1, pp. 111-188
-
Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool
Atherosclerosis Supplements, Vol. 42, pp. e65-e71
-
Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project
Atherosclerosis Supplements, Vol. 42, pp. e49-e58
-
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Annals of Oncology, Vol. 31, Núm. 2, pp. 171-190
2018
-
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
European Heart Journal, Vol. 39, Núm. 14, pp. 1131-1143
-
New prospects for PCSK9 inhibition?
European heart journal
2017
-
2016 ESC/EAS guidelines for the management of dyslipidaemias: The task force for the management of dyslipidaemias of the european society of cardiology (ESC) and european atherosclerosis society (EAS): Developed with the special contribution of the european assocciation for cardiovascular prevention & rehabilitation (EACPR)
Russian Journal of Cardiology
-
European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: Practical guidance for use in patients at very high cardiovascular risk
European Heart Journal, Vol. 38, Núm. 29, pp. 2245-2255
2016
-
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia
European Heart Journal, Supplement, Vol. 18, pp. C2-C12
-
Wytyczne ESC/EAS dotyczace leczenia zaburzeń lipidowych w 2016 roku
Kardiologia Polska, Vol. 74, Núm. 11, pp. 1234-1318
2015
2013
-
2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
European Heart Journal, Vol. 34, Núm. 28, pp. 2159-2219
2010
-
Echocardiography in aortic diseases: EAE recommendations for clinical practice
European Journal of Echocardiography, Vol. 11, Núm. 8, pp. 645-658
-
Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism
European Journal of Echocardiography, Vol. 11, Núm. 6, pp. 461-476